GSK870086 inhalation / GSK  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK870086 inhalation / GSK
NCT00483899: Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects

Completed
1
20
Europe
GW870086X, Placebo
GlaxoSmithKline
Asthma
12/06
12/06
NCT00549497: A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers

Completed
1
36
RoW
GW870086X
GlaxoSmithKline
Asthma
01/08
01/08
NCT01160003: A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.

Completed
1
12
Europe
GW870086X, Placebo
GlaxoSmithKline
Asthma
11/10
11/10
NCT01381445: A Study Assessing GW870086's Potential to Cause Skin Thinning

Completed
1
20
Europe
GW870086 0.2%, GW870086 2%, Clobetasol Propionate, Placebo
GlaxoSmithKline
Dermatitis, Atopic
07/11
07/11

Download Options